Scholars Central

Conference abstract

Characterization of mice and canine glial restricted precursor cells as the potential tools for cell based therapy in experimental models of amyotrophic lateral sclerosis

Authors: Malgorzata Majchrzak, Luiza Stanaszek, Joanna Sanford, Piotr Walczak, Miroslaw Janowski, Barbara Lukomska

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Amyotrophic lateral sclerosis (ALS) is a motor neuron disease with no available treatment that leads to death in less than five years after diagnosis. The experimental studies show a great potential of glial restricted progenitors (GRPs) in treatment of many neurodegenerative disorders, including ALS. One of the greatest advantages of GRPs is their ability to differentiate into both oligodendrocytic and astrocytic cell lineages that play a key role in supporting axon homeostasis and protection of motor neurons. Moreover, mature glial cells are also responsible for myelination processes. Material & Methods: GRPs were extracted from brain and spinal cord of embryonic (E15) transgenic GFP mice (mGRPs) and (E30-35) dogs (dGRPs). Isolated cells were cultured in GRP designed medium (DMEM/F12+B27+N2+heparin+BSA+bFGF) in flasks coated Poly-L-lysine and laminin. GRPs were selected by medium composition and cultured up to the second passage. Both types of GRPs were characterized by immunocytochemistry analysis using the specific primary antibodies: A2B5, GFAP, PDGFRα, MBP, O4, Ng2, CNPase, Olig1, Olig2, Ki67 and CXCR4. Results: Both type of cells, mGRPs and dGRPs show positive reaction with antibodies against early markers of glial progenitors (GFAP, Olig2, CNPase) and negative for mature oligodendrocytes (MBP). They reveal positive markers for proliferation (Ki67) and migration (CXCR4) abilities. Conclusion: The current study shows that cells isolated from fetal nervous system, both mouse and canine have high ability to differentiate into glial progenitor cells. In the future studies, both lines will be used in vivo to assess their therapeutic potential in different experimental ALS mouse models.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Malgorzata Majchrzak”
  • BylineArticles whose byline prints “Luiza Stanaszek”
  • BylineArticles whose byline prints “Joanna Sanford”
  • BylineArticles whose byline prints “Piotr Walczak”
  • BylineArticles whose byline prints “Miroslaw Janowski”
  • BylineArticles whose byline prints “Barbara Lukomska”